Agile Therapeutics Inc (AGRX) stock has gained 50.75% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AGRX stock a score of 67 out of a possible 100.
That rank is primarily influenced by a fundamental score of 97. In addition to the average rating from Wall Street analysts, AGRX stock has a mean target price of 8.5. This means analysts expect the stock to add 183.33% over the next 12 months. AGRX's rank also includes a short-term technical score of 61. The long-term technical score for AGRX is 44.
What's Happening with AGRX Stock Today
Agile Therapeutics Inc (AGRX) stock is flat 0% while the S&P 500 is down -0.1% as of 10:42 AM on Monday, Dec 7. AGRX is flat $0.00 from the previous closing price of $3.00 on volume of 1,040,634 shares. Over the past year the S&P 500 is up 17.84% while AGRX has gained 50.75%. AGRX lost -$0.50 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Agile Therapeutics Inc (AGRX) Stock.